TNGNQ (TNGNQ) Stock Price & Analysis
TNGNQ (TNGNQ) rose 0.00% to USD 0 as of September 9, 2026 at 02:30 UTC, according to Nexqual real-time market data.
TNGNQ last closed at USD 0; the session ranged USD 0–0 on volume of 270,284 shares. Market capitalization is —, with a 52-week range of USD 0–0 (PNK). Source: Nexqual, September 9, 2026 at 02:30 UTC.
Key Statistics (as of September 9, 2026 at 02:30 UTC)
| Price | USD 0 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0 |
| Open | USD 0 |
| Day Range | USD 0 – 0 |
| 52-Week Range | USD 0 – 0 |
| Volume | 270,284 shares |
| Market Cap | — |
| Exchange | PNK |
Technical Analysis (TNGNQ)
Nexqual's technical model rates TNGNQ "NEUTRAL" based on 2 bullish and 2 bearish signals across 127 daily candles, as of September 9, 2026 at 02:30 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 0 (oversold) |
| vs SMA50 | Below (USD 0) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| GNLKQ | GENELINK INC | USD 0 | ▲ 0% |
| RGDXQ | RESPONSE GENETICS INC | USD 0 | ▲ 0% |
| PZRXQ | PHASERX INC | USD 0 | ▲ 0% |
| PFND | PATHFINDER CELL THERAPY INC | USD 0 | ▲ 0% |
| VIAP | VIA PHARMACEUTICALS INC | USD 0 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 9, 2026 at 02:30 UTC. This page is informational and not investment advice.